Figure 3.

Distribution of vaccination status for nirmatrelvir/ritonavir (Paxlovid^TM) recipients, Canada^a, 2022 (n=59,452)

^a Based on data from six reporting jurisdictions. Primary series was defined as either two doses of a vaccine with a two-dose schedule (e.g. mRNA vaccines) or one dose of a vaccine with a one-dose primary series (e.g. Janssen Jcovden^® COVID-19 Vaccine). Incomplete primary series was defined as having received at least one COVID-19 vaccine but not meeting the requirements to have been considered as having completed the primary series, as per information in immunization records